In humans, a combination of immunohistochemical (IHC) markers, including thyroid transcription factor-1 (TTF-1), Napsin A, surfactant protein-A (SP-A), is used to diagnose carcinomas of pulmonary origin (67–72). The gene discussed is NAPSA; the disease is carcinoma.